Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China

ObjectiveThis study aimed to assess whether different clinical trial endpoints in pivotal trials of cancer drugs were associated with reimbursement decisions in China.Materials and methodsCancer drugs marketed before June 30th, 2021 with publicly available technical review reports for application of...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Kexin Ling, Huli Qin, Yiman Feng, Hongxi Che, Jinxi Ding, Wei Li
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2022-11-01
Цуврал:	Frontiers in Public Health
Нөхцлүүд:	cancer drug clinical trial endpoint surrogate endpoint drug price negotiation drug reimbursement decision
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.1062736/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!